5ΜM CPT
BACKGROUND PLASMA MEMBRANE MICROPARTICLE
CD105
CD59
CD59
CPT
CPT
CPT
CPT
CPT
CPT
CPT
CPT ANALOGUE
TREATED HUVEC CULTURE CPT
CPT TREATMENT
DMSO
DMSO
DMSO
TREATED HUVEC DMSO
DNA-FRAGMENTATION
DNA-FRAGMENTATION
ENDOTHELIAL ANTIGEN
FSC
FSC
FLOW CYTOMETRY ANALYSIS
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUVEC MP COUNT
HUVEC CULTURE
HUVEC CULTURE SUPERNATANT
REACHING CONFLUENCE HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
LIPOPOLYSACCHARIDE
MICROPARTICLES
MICROPARTICLES
MICROPARTICLES
MICROPARTICLES
MICROPARTICLES
MICROPARTICLES
MICROPARTICLES
MP COUNT
MP DETECTION
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
MP-RELEASE
NIH
PHOSPHATIDYLSERINE
PHOSPHATIDYLSERINE
PHOSPHATIDYLSERINE
PS-CONTAINING MEMBRANE MP
PS-EXPOSING MP
PLASMA MEMBRANE BLEBBING
PROAPOPTOTIC
SSC
SIMILAR SHORT-TIME ACTIVATION
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL SIMILAR SHORT-TIME ACTIVATION
TNFΑ
TNFΑ
TNFΑ
TUNEL
TUNEL-POSITIVITY
USING FLOW CYTOMETRY
ZVAD
ZVAD
ACTIVATING PEPTIDE
ADHERENT CELL
AFFINITY
PHOSPHATIDYLSERINE AFFINITY
AGONIST
AGONIST
AGONIST
AGONIST
ANALYZED MP
ANNEXIN
ANNEXIN
ANNEXIN
ANNEXIN
ANNEXIN
ANNEXIN
ANNEXIN
ANNEXIN
ANNEXIN V-FITC
ANTICOAGULANT FUNCTION
ANTIGEN
ANTINEOPLASTIC AGENT
APOPTOSI
APOPTOSI
APOPTOSI
ADHERENT CELL APOPTOSI
APOPTOTIC T-LYMPHOCYTE
APOPTOTIC BODY
APOPTOTIC BODY
APOPTOTIC CELL
APPEARED NEGATIVE
BLOOD PLATELET
CALPAIN-DEPENDENT DISSOCIATION
CAMPTOTHECIN
CAMPTOTHECIN PHASE CONTRAST MICROSCOPY
CARRYING ENDOTHELIAL ANTIGEN
CATALYTIC SURFACE
CELL APOPTOSI
CELL APOPTOSI
CELL DESQUAMATION
CELL SUPERNATANT
CELLULAR ACTIVATION
CELLULAR ORIGIN
CHEMOTACTIC PEPTIDE FMLP
CIRCULATING MP
CIRCULATING MP
COLLAGEN
CONCENTRATION
CONCENTRATION
CONCENTRATION
CPT CONCENTRATION
CPT CONCENTRATION
IONOPHORE CONCENTRATION
CONFLUENCE
CONFLUENCE
CONTROL CELL
CONTROL CULTURE
CORONARY SYNDROME
CULTURE MATURATION
CYCLOHEXIMIDE
CYCLOHEXIMIDE TREATMENT
DETERMINANT
PHAGOCYTE RECOGNITION DETERMINANT
DIAGNOSTIC MARKER
VESSEL WALL INJURY DIAGNOSTIC MARKER
ENDOTHELIAL MP
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
ENDOTHELIAL CELL
RELEASE MP ENDOTHELIAL CELL
ENDOTHELIAL INJURY
ENDOTHELIAL ORIGIN
ENDOTOXIN-STIMULATED MONOCYTE
EXACERBATED MULTIPLE SCLEROSIS
FLOW CYTOMETRY
HOMOGENEOUS POPULATION
SINGLE LIVING CELL HOMOGENEOUS POPULATION
HR
HR
HR
HR
HR
HR
HR
HR
HR
HRS INCUBATION
HUMAN ANGIOTENSIN II
HUMAN THROMBIN
HUMAN THROMBIN RECEPTOR
ACTIVATING PEPTIDE HUMAN THROMBIN RECEPTOR
HUMAN TISSUE PLASMINOGEN ACTIVATOR
INCREASED COUNT
MICROPARTICLES INCREASED COUNT
CARRYING ENDOTHELIAL ANTIGEN MICROPARTICLES INCREASED COUNT
INCREASED PLASMA COUNT
ENDOTHELIAL MP INCREASED PLASMA COUNT
INDUCED MP-RELEASE
INDUCTION
APOPTOSI INDUCTION
INHIBITOR CAMPTOTHECIN
INTRACELLULAR
IONOPHORE
KU/ML
LUPUS ANTICOAGULANT
MATURATION
MEMBRANE MP
MEMBRANE MICROPARTICLE
MEMBRANE MICROPARTICLE
USING FLOW CYTOMETRY MEMBRANE MICROPARTICLE
MEMBRANE VESICULATION
MICROPARTICLE
MICROPARTICLE
FLOW CYTOMETRY ANALYSIS MICROPARTICLE
MIN TREATMENT
MORPHOLOGICAL CHANGE
MULTIPLE MECHANISM
NM
NM
NM CPT
NM CPT
NM CAMPTOTHECIN
INDUCED MP-RELEASE NM CAMPTOTHECIN
NECROTIC CELL
PHAGOCYTE RECOGNITION
PHORBOL MYRISTATE ACETATE
PHOSPHATIDYLSERINE
PHOSPHOLIPID-BINDING PROTEIN ANNEXIN V
PLATELET PROTEIN KINAS
PLATELET
PLATELET
POLYMORPHONUCLEAR LEUCOCYTE
POSSIBLE PATHOPHYSIOLOGICAL ROLE
CIRCULATING MP POSSIBLE PATHOPHYSIOLOGICAL ROLE
PROAPOPTOTIC STIMULATION
PROCOAGULANT
PROINFLAMMATORY
PROPIDIUM IODIDE
PROPIDIUM IODIDE
PROPIDIUM IODIDE ASSAY
PROTEIN C
PROTHROMBINASE COMPLEX
REACHING CONFLUENCE
RELEASE MP
REMAINING ADHERENT
REMAINING ADHERENT CELL
SHOWED ANNEXIN REMAINING ADHERENT CELL
SHOWED ANNEXIN
SINGLE LIVING CELL
SPONTANEOUS APOPTOSI
STANDARD BEAD
STANDARD BEAD
SUBCONFLUENT HUVEC
SUBMEMBRANE CYTOSKELETON
THROMBIN
THROMBIN
THROMBOTIC THROMBOCYTOPENIC PURPURA
TOPOISOMERASE I
TOPOISOMERASE I
INHIBITOR CAMPTOTHECIN TOPOISOMERASE I
TREATED HUVEC
TREATED HUVEC CULTURE
UMBILICAL VEIN ENDOTHELIAL CELL
VESSEL WALL INJURY
ΜM
ΜM CPT
ΜM CPT
ΜM CPT
ΜM CPT
ΜM CPT
ΜM CPT TREATMENT
ΜM IONOPHORE
ΜG/ML
ΜG/ML
ΜG/ML
ΜM
ΜMOL/L
ΜMOL/L
MICROPARTICLES
MP
PS
HUMAN UMBILICAL VEIN ENDOTHELIAL CELL
HUVEC
PMA
THROMBIN RECEPTOR ACTIVATING PEPTIDE
TRAP
THROMBIN
THR
TISSUE PLASMINOGEN ACTIVATOR
TPA
ANGIOTENSIN II
AGTII
CPT
treatments
ENDOTHELIAL
FLOW CYTOMETRY
CYTOMETRY ANALYSIS
cytometry
MP COUNT
MP
culture supernatants
counts
detection
MEMBRANE MP
MP
membrane blebbing
SHORT-TIME ACTIVATION
FLOW CYTOMETRY
peptides
adherent
MP
ANNEXIN
anticoagulant
functions
ANTINEOPLASTIC
apoptotic
apoptotic
apoptotic
apoptotic
dissociation
CAMPTOTHECIN
CARRYING ENDOTHELIAL
ENDOTHELIAL
DESQUAMATION
activation
origins
PEPTIDE FMLP
peptides
MP
MP
controls
controls
MATURATION
CYCLOHEXIMIDE
treatments
markers
ENDOTHELIAL
MP
ENDOTHELIAL
ENDOTHELIAL
ENDOTHELIAL
ENDOTHELIAL
ENDOTHELIAL
ENDOTHELIAL
injury
ENDOTHELIAL
origins
ENDOTOXIN-STIMULATED
cytometry
populations
INCUBATION
THROMBIN
HUMAN THROMBIN
THROMBIN RECEPTOR
THROMBIN
TISSUE PLASMINOGEN ACTIVATOR
plasminogen activator
plasminogen
MP-RELEASE
inhibitors
CAMPTOTHECIN
anticoagulant
MP
VESICULATION
min
treatments
MULTIPLE
NM
CPT
NM
CPT
NM
CAMPTOTHECIN
NECROTIC
RECOGNITION
myristate
ANNEXIN
PLATELET
polymorphonuclear
PROAPOPTOTIC
STIMULATION
propidium
IODIDE
propidium
IODIDE
PROPIDIUM IODIDE
propidium
IODIDE
CONFLUENCE
RELEASE
MP
adherent
REMAINING ADHERENT
ANNEXIN
standards
standards
HUVEC
cytoskeleton
THROMBOCYTOPENIC PURPURA
topoisomerases
topoisomerases
HUVEC
TREATED HUVEC
HUVEC
ENDOTHELIAL
vessels
WALL INJURY
ΜM
CPT
ΜM
CPT
ΜM
CPT
ΜM
CPT
ΜM
CPT
ΜM CPT
ΜM
CPT TREATMENT
CPT
ΜM
IONOPHORE
